Table 2.
Characteristic | NC
(n = 316) |
SZ
(n = 106) |
BD
(n = 66) |
Statistic | p < |
---|---|---|---|---|---|
Age (years) | 54.5 ±18.6a | 40.0 ±11.1b | 41.5 ±11.5b | F(2,483) = 39.6 | 0.001 |
Sex (male:female %) | 44:56a | 69:31b | 38:62a | 0.001 | |
Race (w:b:o %) | 81:17:2a | 40:55:6b | 67:29:5c | 0.001 | |
Education (years) | 14.3 ±3.0a | 12.0 ±2.4b | 14.8 ±3.0a | F(2,483) = 27.6 | 0.001 |
Est. premorbid IQ | 105.2 ±10.1a | 96.5 ±10.5b | 103.7 ±10.9a | F(2,483) = 28.3 | 0.001 |
Age at onset (years) | – | 22.9 ±7.5 | 24.9 ±9.0 | t(98.5) = -1.5 | 0.163 |
Illness duration (years) | – | 17.1 ±10.5 | 16.3 ±11.1 | t(143) = 0.5 | 0.647 |
# Hospitalizations | – | 5.4 ±6.5 | 4.2 ±4.4 | t(143) = 1.2 | 0.244 |
SANS (sum) | – | 10.0 ±6.4 | 2.5 ±2.9 | t(83.6) = 7.8 | 0.001 |
SAPS (sum) | – | 5.1 ±4.1 | 1.8 ±2.6 | t(90.6) =4.3 | 0.001 |
Typical antipsychotic (%) | – | 34 | 4 | 0.001 | |
Atypical antipsychotic (%) | – | 75 | 47 | 0.001 | |
Any antidepressant (%) | – | 23 | 48 | 0.001 | |
Lithium (%) | – | 4 | 50 | 0.001 | |
Any anticonvulsant (%) | – | 13 | 42 | 0.001 |
Note: For three-group analyses, different subscripts denote significant (p < .05) differences. SZ = schizophrenia; BD = bipolar disorder; NC = normal control. Estimated premorbid IQ based on the NART-R (Blair and Spreen 1989).
Shown as mean ±standard deviation unless otherwise indicated.
2For race, w = white, b = black, o = “other.”